Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Use corticosteroid cream and triamcinolone injections for treating alopecia areata, and consider wigs and tranquilizers for support.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

SVF and PRP improve hair loss, but SVF causes more side effects.

The new drug carriers show promise for better targeting and treating ovarian cancer.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Common skin conditions can greatly affect a person's mental health and social life.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.